FDA gives nod to RSV vaccine for people in their 50s

The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup